# Hainan Cat's Claw Reishi (Ganoderma lucidum 'Hainan Cat's Claw')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/hainan-cat-s-claw-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum 'Hainan Cat's Claw', Hainan Cat's Claw Lingzhi, Cat's Claw Reishi variant, Hainan Reishi cultivar, Cat's Claw Ganoderma

## Overview

Hainan Cat's Claw Reishi is a cultivar variant of Ganoderma lucidum purportedly combining reishi mushroom triterpenoids and [beta-glucan](/ingredients/condition/immune-support)s with cat's claw alkaloids, though no clinical evidence currently validates benefits specific to this hybrid cultivar. Its proposed mechanisms draw from parent species research, where ganoderic acids modulate immune signaling and oxindole alkaloids from Uncaria tomentosa inhibit NF-κB [inflammatory pathway](/ingredients/condition/inflammation)s.

## Health Benefits

• No documented benefits for this specific cultivar variant - evidence quality: absent
• Standard Ganoderma lucidum showed improved well-being scores in neurasthenia patients (n=132 RCT) - evidence quality: moderate
• Uncaria tomentosa reduced knee osteoarthritis pain in RCT (n=40, P<0.05) - evidence quality: moderate
• Cat's Claw extracts demonstrated [anti-inflammatory](/ingredients/condition/inflammation) effects in 2024 systematic review of animal studies - evidence quality: preliminary
• Traditional use suggests potential for inflammation and arthritis, but no human trials for this variant - evidence quality: traditional only

## Mechanism of Action

Standard Ganoderma lucidum triterpenoids, particularly ganoderic acids A and B, inhibit HMG-CoA reductase and modulate Toll-like receptor 4 (TLR4) signaling, suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s TNF-α and IL-6. [Beta-glucan](/ingredients/condition/immune-support)s from the fruiting body bind Dectin-1 receptors on macrophages, activating CARD9-mediated innate immune responses. If cat's claw alkaloids such as isopteropodine are present in this cultivar, they may additionally inhibit NF-κB nuclear translocation, though this combined pharmacodynamic profile has not been confirmed for this specific variant.

## Clinical Summary

No randomized controlled trials or observational studies have been conducted on Hainan Cat's Claw Reishi as a distinct cultivar, making evidence quality absent for this specific form. Evidence extrapolated from parent species includes an RCT of 132 neurasthenia patients showing improved well-being scores with standard Ganoderma lucidum supplementation. A separate RCT of 40 patients with knee osteoarthritis demonstrated statistically significant pain reduction (P<0.05) with Uncaria tomentosa supplementation. Consumers and clinicians should not assume that benefits documented for either parent species automatically transfer to this cultivar without direct supporting research.

## Nutritional Profile

Note: 'Hainan Cat's Claw Reishi' is not a formally recognized cultivar in peer-reviewed mycological literature; no dedicated compositional analyses exist. The following profile is extrapolated from standard Ganoderma lucidum fruiting body data, with caveats that regional Hainan strains may differ in triterpenoid ratios due to tropical growing conditions. **Macronutrients (per 100 g dry weight, approximate):** Protein 10–18 g (rich in glutamic acid, aspartic acid; true digestibility ~60–70% due to chitin-bound matrix), Total carbohydrates 55–70 g (of which β-glucans 25–45 g, primarily β-1,3/1,6-D-glucans; chitin-derived dietary fiber 10–15 g), Fat 2–5 g (dominated by oleic and linoleic acids; small fraction of ergosterol ~0.3–0.6 g, convertible to vitamin D2 under UV exposure). **Key Bioactive Compounds:** Ganoderic acids (triterpenoids, typically 1–5% dry weight; subtypes A, B, C, D, F predominate; oral bioavailability is low, estimated <5% without lipid co-administration), Polysaccharides (β-D-glucans ~25–45% dry weight; [immunomodulatory](/ingredients/condition/immune-support) fractions with MW 10–1000 kDa; bioavailability improved by hot-water extraction), Ganodermanontriol and lucidenic acids (minor triterpenoids, <0.5%), Sterols including ergosterol (~0.3–0.6%), Peptidoglycans (protein-bound polysaccharides). **Micronutrients:** Potassium 300–600 mg, Phosphorus 200–400 mg, Calcium 30–80 mg, Magnesium 20–50 mg, Zinc 3–8 mg, Selenium 1–5 µg (highly substrate-dependent; Hainan volcanic soils may elevate Se content), Iron 3–10 mg, Copper 1–3 mg, Germanium (organic, trace, ~20–60 µg — often cited but poorly validated). **Vitamins:** B-complex vitamins in modest amounts (riboflavin ~0.2–0.5 mg, niacin ~3–8 mg per 100 g dry), Vitamin D2 trace unless UV-treated (can reach 50–100 µg/100 g post-UV). **Bioavailability Notes:** Triterpenoids are poorly water-soluble; dual extraction (hot water + ethanol) maximizes recovery of both polysaccharide and triterpenoid fractions. Chitin cell walls limit nutrient release unless thermally processed or enzymatically treated. The 'Cat's Claw' designation in the common name likely references morphological features (claw-shaped fruiting body or branching) rather than the presence of Uncaria-type oxindole alkaloids — no alkaloid content analogous to Uncaria tomentosa has been documented in any Ganoderma species. Consumers should not expect cat's claw (Uncaria) bioactives from this fungus.

## Dosage & Preparation

No clinically studied dosages exist for Hainan Cat's Claw Reishi. Standard Ganoderma lucidum polysaccharide extract: 5.4g/day (equivalent to 81g dry mushroom). Uncaria tomentosa: 100mg/day freeze-dried extract (20mg oxindole alkaloids). Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Standard Ganoderma lucidum is generally well tolerated but may cause gastrointestinal upset, dry mouth, or dizziness, particularly at doses exceeding 1.5 g/day of concentrated extract. Uncaria tomentosa components carry a risk of potentiating anticoagulant and antiplatelet drugs such as warfarin and aspirin due to inhibition of platelet aggregation, and this interaction risk may carry over to this cultivar if cat's claw alkaloids are present. This ingredient is contraindicated in individuals with autoimmune conditions such as lupus or rheumatoid arthritis on immunosuppressive therapy, as immune-stimulating [beta-glucan](/ingredients/condition/immune-support)s may exacerbate these conditions. Pregnancy and breastfeeding safety has not been established for this cultivar or for Uncaria tomentosa, and use should be avoided without medical supervision.

## Scientific Research

No human clinical trials exist for Hainan Cat's Claw Reishi. Standard Ganoderma lucidum was tested in one double-blind RCT (n=132) using 5.4g/day polysaccharide extract for neurasthenia, while Uncaria tomentosa showed pain reduction in a small osteoarthritis RCT (n=40, PMID: 11603848). A 2024 systematic review confirmed [anti-inflammatory](/ingredients/condition/inflammation) effects of Cat's Claw in animal models only.

## Historical & Cultural Context

While this specific cultivar lacks documentation, Ganoderma lucidum has been used in Asian traditional medicine for centuries for cancer, diabetes, and neurasthenia. Uncaria tomentosa has traditional use in Peruvian medicine for arthritis, gastritis, and [inflammation](/ingredients/condition/inflammation).

## Synergistic Combinations

Standard Reishi, Uncaria tomentosa, Turmeric, Boswellia, Ginger

## Frequently Asked Questions

### Is there clinical evidence for Hainan Cat's Claw Reishi specifically?

No clinical trials have been conducted on Hainan Cat's Claw Reishi as a distinct cultivar variant. All available evidence comes from separate studies on Ganoderma lucidum and Uncaria tomentosa individually, and it cannot be assumed that combining these species into a single cultivar produces equivalent or additive effects without direct human trial data.

### What compounds are active in Hainan Cat's Claw Reishi?

The proposed active compounds include ganoderic acids and beta-glucans derived from the Ganoderma lucidum lineage, along with oxindole alkaloids such as isopteropodine and mitraphylline associated with Uncaria tomentosa. However, the actual alkaloid and triterpenoid profile of this specific cultivar has not been independently verified through phytochemical analysis in published literature.

### How does Hainan Cat's Claw Reishi compare to standard Reishi mushroom?

Standard Ganoderma lucidum has moderate-quality clinical evidence from trials including a 132-patient RCT demonstrating improved well-being in neurasthenia, while Hainan Cat's Claw Reishi lacks any cultivar-specific data. The addition of cat's claw characteristics is theoretically intended to add anti-inflammatory alkaloid activity via NF-κB inhibition, but this distinction remains unvalidated in clinical or robust phytochemical research.

### Can Hainan Cat's Claw Reishi interact with blood thinners?

Based on the pharmacology of its constituent species, there is a plausible risk of interaction with anticoagulant medications such as warfarin and antiplatelet agents like aspirin or clopidogrel. Uncaria tomentosa has demonstrated inhibition of platelet aggregation in vitro, and Ganoderma lucidum has shown anticoagulant activity in preclinical models. Individuals on these medications should consult a physician before using this supplement.

### What is the recommended dosage for Hainan Cat's Claw Reishi?

No evidence-based dosage has been established for this specific cultivar due to the absence of clinical trials. Doses used in Ganoderma lucidum trials typically range from 1.44 g to 5.4 g of dried mushroom equivalent daily, while Uncaria tomentosa studies have used 100 mg of standardized extract for joint conditions. Any dosing approach for this cultivar remains speculative and should be guided by a qualified healthcare provider.

### Is Hainan Cat's Claw Reishi safe during pregnancy and breastfeeding?

There is insufficient safety data specifically for Hainan Cat's Claw Reishi during pregnancy and breastfeeding, so this cultivar variant should be avoided during these periods as a precautionary measure. Standard Reishi mushroom is often considered cautious during pregnancy due to its immune-modulating properties. Consult a healthcare provider before using any Reishi product if you are pregnant or nursing.

### Who is most likely to benefit from Hainan Cat's Claw Reishi supplementation?

While specific clinical evidence for this cultivar is absent, individuals seeking traditional immune support and stress reduction may consider it based on standard Reishi's moderate evidence in improving well-being in neurasthenia and fatigue-related conditions. Those with inflammatory concerns might explore it given the documented anti-inflammatory effects of Cat's Claw extracts, though the specific cultivar's efficacy remains unstudied. Anyone with chronic conditions should consult a healthcare provider before use.

### What is the difference between Hainan Cat's Claw Reishi and standard Reishi in terms of origin and cultivation?

Hainan Cat's Claw Reishi is a specific cultivar variant of Ganoderma lucidum grown in Hainan, China, and is distinguished by morphological features that resemble cat's claw structures, whereas standard Reishi refers to the broader species without this specific regional or morphological designation. The Hainan origin may influence growing conditions and compound expression, though comparative cultivation data is limited. No published studies directly compare the bioactive profiles or efficacy of this cultivar against other Ganoderma lucidum varieties.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*